Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients

Background and Aim. This is an open label prospective cohort study conducted at a tertiary care hospital. The primary endpoint is SVR12 in patients treated with sofosbuvir-based therapy in post-liver transplant patients with genotype 4 HCV recurrence. Methodology. Thirty-six treatment-experienced li...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajlan, A., Al-Jedai, A., Elsiesy, H., Alkortas, D., Al-Hamoudi, W., Alarieh, R., Al-Sebayel, M., Broering, D., Aba Alkhail, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904700/
https://www.ncbi.nlm.nih.gov/pubmed/27446833
http://dx.doi.org/10.1155/2016/2872371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904700/
https://www.ncbi.nlm.nih.gov/pubmed/27446833
http://dx.doi.org/10.1155/2016/2872371

Ejemplares similares